| Date Filed | Type | Description |
| 09/27/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 09/27/2023 |
8-K
| Quarterly results |
| 08/22/2023 |
4
| CONKLING WILLIAM (Director) has filed a Form 4 on Cyclo Therapeutics, Inc.|
Txns:
| Granted 2,449 shares
@ $0 |
|
| 08/22/2023 |
4
| Ostronic Francis Patrick (Director) has filed a Form 4 on Cyclo Therapeutics, Inc.|
Txns:
| Granted 10,111 shares
@ $0 |
|
| 08/22/2023 |
4
| SHANAHAN WILLIAM S (Director) has filed a Form 4 on Cyclo Therapeutics, Inc.|
Txns:
| Granted 9,835 shares
@ $0 |
|
| 08/22/2023 |
4
| Sieger Markus (Director) has filed a Form 4 on Cyclo Therapeutics, Inc.|
Txns:
| Granted 16,269 shares
@ $0 |
|
| 08/22/2023 |
4
| STRATTAN CE RICK (Director) has filed a Form 4 on Cyclo Therapeutics, Inc.|
Txns:
| Granted 8,089 shares
@ $0 |
|
| 08/22/2023 |
4
| Toig Randall M. (Director) has filed a Form 4 on Cyclo Therapeutics, Inc.|
Txns:
| Granted 8,732 shares
@ $0 |
|
| 08/21/2023 |
4
| Wong Vivien (Director) has filed a Form 4 on Cyclo Therapeutics, Inc.|
Txns:
| Granted 6,700 options to buy
@ $1.26, valued at
$8.4k
|
|
| 08/21/2023 |
3
| Wong Vivien (Director) has filed a Form 3 on Cyclo Therapeutics, Inc. |
| 08/21/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/07/2023 |
SC 13D/A
| Rafael Holdings, Inc. reports a 49% stake in Cyclo Therapeutics, Inc. |
| 08/03/2023 |
8-K
| Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits Interactive Data |
| 08/02/2023 |
4
| Rafael Holdings, Inc. (10% Owner) has filed a Form 4 on Cyclo Therapeutics, Inc.|
Txns:
| Bought 4,000,000 shares
@ $1.25, valued at
$5M
Bought 4,000,000 warrants
@ $1.25, valued at
$5M
|
|
| 07/31/2023 |
8-K
| Quarterly results |
| 06/07/2023 |
4
| CONKLING WILLIAM (Director) has filed a Form 4 on Cyclo Therapeutics, Inc.|
Txns:
| Granted 6,700 options to buy
@ $1.37, valued at
$9.2k
|
|
| 06/02/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 05/19/2023 |
4
| STRATTAN CE RICK (Director) has filed a Form 4 on Cyclo Therapeutics, Inc.|
Txns:
| Granted 21,360 shares
@ $0 |
|
| 05/18/2023 |
4
| SHANAHAN WILLIAM S (Director) has filed a Form 4 on Cyclo Therapeutics, Inc.|
Txns:
| Granted 25,971 shares
@ $0 |
|
| 05/18/2023 |
4
| Sieger Markus (Director) has filed a Form 4 on Cyclo Therapeutics, Inc.|
Txns:
| Granted 42,962 shares
@ $0 |
|
| 05/18/2023 |
4
| Toig Randall M. (Director) has filed a Form 4 on Cyclo Therapeutics, Inc.|
Txns:
| Granted 23,059 shares
@ $0 |
|
| 05/18/2023 |
4
| Ostronic Francis Patrick (Director) has filed a Form 4 on Cyclo Therapeutics, Inc.|
Txns:
| Granted 26,700 shares
@ $0 |
|
| 05/18/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and... |
| 05/12/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/11/2023 |
SC 13D
| Rafael Holdings, Inc. reports a 16.6% stake in Cyclo Therapeutics, Inc. |
| 05/08/2023 |
3
| Rafael Holdings, Inc. (10% Owner) has filed a Form 3 on Cyclo Therapeutics, Inc. |
| 05/08/2023 |
3
| CONKLING WILLIAM (Director) has filed a Form 3 on Cyclo Therapeutics, Inc. |
| 05/04/2023 |
8-K
| Quarterly results |
| 05/01/2023 |
10-K/A
| Annual Report for the period ended December 31, 2022 [amend] |
| 04/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|